Please assess the completion status of the following clinical trial:

Trial Title: Whole Blood Biospecimen Collection for Subjects With Chronic Granulomatous Disease (CGD)

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: OTHER
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* The participant is willing and able to provide written informed consent~* The participant is willing and able to provide appropriate photo identification~* Participants aged 18 to 85~* Participants have been diagnosed with Chronic Granulomatous Disease (CGD)~* Subjects who have a confirmed p47phox CGD mutation or Subjects who have a confirmed X-linked CGD mutation~Exclusion Criteria:~* Participants who are pregnant or are nursing~* Participants with a known history of HIV, hepatitis, or other infectious diseases~* Participants who have taken an investigational product in the last 30 days~* Participants who have experienced excess blood loss, including blood donation, defined as 250 mL in the last month or 500 mL in the previous two months

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- CGD with p47phox phenotype (Type: None): None
- X-Linked CGD (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).